Talphera (TLPH) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for October 23, 2025, with virtual participation available for shareholders.
Shareholders are encouraged to review proxy materials and vote by October 22, 2025.
Voting matters and shareholder proposals
Election of three directors: Vincent J. Angotti, Stephen Hoffman, M.D., Ph.D., and Abhinav Jain, with board recommending votes in favor.
Ratification of BPM LLP as independent registered public accounting firm for fiscal year ending December 31, 2025.
Advisory approval of executive compensation and preferred frequency for future say-on-pay votes, with board recommending annual votes.
Approval of Amended and Restated 2020 Equity Incentive Plan and 2011 Employee Stock Purchase Plan.
Approval of an amendment to the Certificate of Incorporation to effect a reverse stock split of common stock.
Board of directors and corporate governance
Board recommends all director nominees and all proposals presented for shareholder approval.
Latest events from Talphera
- Q2 net loss narrowed, $14M cash, NEPHRO study expanded, but more funding needed soon.TLPH
Q2 20241 Feb 2026 - Pivotal phase III trial of Niyad targets 2025 finish, with strong IP and market prospects.TLPH
Maxim Group’s 2024 Healthcare Virtual Summit19 Jan 2026 - NEPHRO CRRT trial advances, net loss is $3.4M, and $11.1M cash on hand; more funding needed.TLPH
Q3 202414 Jan 2026 - FDA-approved protocol changes and $14.8M financing support NEPHRO CRRT study completion.TLPH
Q4 202424 Dec 2025 - Resale registration for shares and warrants from a private placement; no new capital raised.TLPH
Registration Filing16 Dec 2025 - Shares and warrants from a $17M private placement registered for resale; no proceeds to issuer.TLPH
Registration Filing16 Dec 2025 - Resale registration for shares and warrants from a $1.6M private placement; no proceeds to issuer.TLPH
Registration Filing16 Dec 2025 - Proxy covers director elections, equity plan changes, and a reverse split for Nasdaq compliance.TLPH
Proxy Filing1 Dec 2025 - Key votes include director elections, equity plan increases, and a reverse stock split for Nasdaq compliance.TLPH
Proxy Filing1 Dec 2025